Endocrine Abstracts

Background and Aims: There are consistent findings about increased prevalence of depressive disorders in diabetes. The aim of the study was to reveal prevalence of depression in patients (pts) with type 1 (DM1) and type 2 (DM2) diabetes.Materials and Methods: Totally, 157 pts with DM were questioned. To assess depression degree Beck’s scale was used, and 83 depressive pts (scores >10), were allocated into 2 groups (Gr.): Gr.1 (n=44)–...

Background: The different changes are seen on skin and it’s accessories in patients (pts) with Type 2 Diabetes (T2D); some of them represent the prognostic indicator of complicated diabetes and some directly contribute in development of them. The aim of our study was to examine the prevalence of characteristic changes of skin and its accessories in T2D considering the grade of severity of Diabetic Peripheral Neuropathy (DPN).Materials and methods: T...

Background and Aims: Components of metabolic syndrome (MS) carry an increased risk for cardiovascular disease (CVD). People with abnormal glucose regulation are more prone to develop complications. At diagnosis 20-30% of type 2 diabetic (T2DM) patients (pts) already have neuropathy-one of the most dangerous complications. Cardiac autonomic neuropathy (CAN) is associated with five-fold risk of mortality. Our aim was to study possible relation between CAN and some components of ...

Background and aims: Combination of drugs, affecting early insulin secretion and peripheral insulin resistance are a good therapeutic option for patients (pts) with type 2 diabetes mellitus (T2DM). The aim of the present work was to compare efficacy of Repaglinide+Metformin and Sulphonilurea+Metformine in obese T2DM pts.Materials and methods: A total of 107 pts with T2DM not well-controlled on monotherapy. Repaglinide - naïve were allocated into 2 g...

Background and Aims: At diagnosis 20–30% of patients (pts) with type2 diabetes (T2DM) have neuropathy, that often goes unrecognized. Cardiac autonomic neuropathy (CAN) is associated with five-fold risk of mortality. As today there is no specific treatment for overt neuropathy, it is important to use prevention and timely revealing. The goal of the work was to evaluate prevalence of peripheral neuropathy and CAN in pts with newly diagnosed T2DM.Mater...